Financial Disclosure for Dr. Douglas A. Stewart
Content provided by Healthwise
Financial Disclosure for Dr. Douglas A. Stewart
- $90,000 one-time grant received from Hoffman La Roche, September 2001.
- Honoraria received from Ortho-Biotech (Eprex, Velcade), Hoffman La Roche (Rituximab), GSK (Bexxar), and Berlex (Zevalin).
| Last updated: | November 18, 2004 |
|---|
© 1995-2007, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, and AOL Body Advertising Policy. Read more about our content partners.
Search
Where Does it Hurt?
If you're experiencing aches and pains we can help you find answers. Find out what your symptoms mean for your health.
